235 related articles for article (PubMed ID: 30081707)
1. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells.
Wang Y; Zhang R; Cheng G; Xu R; Han X
Cell Cycle; 2018; 17(13):1637-1648. PubMed ID: 30081707
[TBL] [Abstract][Full Text] [Related]
2. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.
Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q
Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
Xiao S; Song B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p.
Liu Y; Lin X; Zhou S; Zhang P; Shao G; Yang Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064819
[No Abstract] [Full Text] [Related]
9. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1.
Wang Z; Wang Z; Liu J; Yang H
Biomed Pharmacother; 2018 Nov; 107():598-605. PubMed ID: 30114643
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA HOXA-AS2 Inhibits Viability, Migration and Invasion of Osteosarcoma Cells by miR-124-3p/E2F3.
Wang L; Wang L; Zhang X
Onco Targets Ther; 2019; 12():10851-10861. PubMed ID: 31853184
[TBL] [Abstract][Full Text] [Related]
14. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway.
Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
Biomed Pharmacother; 2018 Nov; 107():270-282. PubMed ID: 30098545
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding HOXA-AS3 contributes to osteosarcoma progression through the miR-1286/TEAD1 axis.
Xiao X; Liu M; Xie S; Liu C; Huang X; Huang X
J Orthop Surg Res; 2023 Sep; 18(1):730. PubMed ID: 37752588
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
Liu W; Liu P; Gao H; Wang X; Yan M
Mol Oncol; 2020 Oct; 14(10):2660-2677. PubMed ID: 32412676
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ODRUL regulates progression of osteosarcoma by regulating IL-6 via sponging miR-6874-3p.
Zhan T; Zhu K; Hu J; Ma X; Zhu Y; Zhang C
Exp Cell Res; 2022 Mar; 412(2):113050. PubMed ID: 35114192
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
Xin J; Zhao YH; Zhang XY; Tian LQ
Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
[TBL] [Abstract][Full Text] [Related]
19. HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.
Sun J; Wang L
BMC Cancer; 2022 Apr; 22(1):366. PubMed ID: 35387643
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00313 Knockdown Inhibits Tumorigenesis and Metastasis in Human Osteosarcoma by Upregulating FOSL2 through Sponging miR-342-3p.
Chen H; Wahafu P; Wang L; Chen X
Yonsei Med J; 2020 May; 61(5):359-370. PubMed ID: 32390359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
